Effects of sub-chronic antipsychotic drug treatment on body weight and reproductive function in juvenile female rats

Psychopharmacology

Volumn 182, Issue 4, 2005, Pages 499-507

  Fell, M J ^a   Neill, J C ^a   Rao, C ^a   Marshall, K M ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Antipsychotic; Food intake; Haloperidol; Juvenile rat; Olanzapine; Reproductive dysfunction; Risperidone; Sulpiride; Weight gain; Ziprasidone

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SULPIRIDE; ZIPRASIDONE;

ARTICLE; BODY FAT; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; ESTRUS CYCLE; FEMALE; FLUID INTAKE; FOOD INTAKE; NONHUMAN; PRIORITY JOURNAL; RAT; SEXUAL BEHAVIOR; SEXUAL FUNCTION; STATISTICAL SIGNIFICANCE; WEIGHT GAIN;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; BODY WEIGHT; DRINKING; DRUG ADMINISTRATION SCHEDULE; EATING; ESTROUS CYCLE; FEMALE; ORGAN SIZE; RATS; REPRODUCTION; TIME FACTORS; UTERUS;

EID: 26844445669     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0131-3     Document Type: Article

References (51)

1. Abdul-Monim Z, Reynolds GP, Neill JC (2003) The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat. J Psychopharmacol 17:57-65
2. Allison DB, Casey DEU (2001) Antipsychotic-induced weight gain: a review of literature. J Clin Psychiatry 62:22-31
3. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156:1686-1696
4. Arjona AA, Wurtman RJ, Zhang SX, Adamson B (2004) An animal model of antipsychotic-induced weight gain. Behav Brain Res 152:121-127
5. Baptista T (2002) Mechanisms of weight gain induced by antipsychotic drugs. J Clin Psychiatry 63:245-246
6. Baptista T, Parada M, Hernandez L (1987) Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved? Pharmacol Biochem Behav 27:399-405
7. Baptista T, Parada MA, Murzi EU (1988) Puberty modifies sulpiride effects on body weight in rats. Neurosci Lett 92:161-164
8. Baptista T, Contreras Q, Teneud L, Albornoz MA, Acosta A, Paez X, de Quijada M, LaCruz A, Hernandez L (1998) Mechanism of the neuroleptic-induced obesity in female rats. Prog Neuro-Psychopharmacol Biol Psychiatry 22:187-198
9. Baptista T, Araujo de Baptista E, Ying Kin NM, Beaulieu S, Walker D, Joober R, Lalonde J, Richard D (2002a) Comparative effects of the antipsychotics sulpiride or risperidone in rats. I. Bodyweight, food intake, body composition, hormones and glucose tolerance. Brain Res 957:144-151
10. Baptista T, Lacruz A, De Mendoza D, Mendoza JM, Silvera R, Angeles F, Mendoza MT, Hernandez L (2002b) Body weight gain after administration of antipsychotic drugs. Pharmacopsychiatry 35:36
11. Baptista T, de Baptista EA, Lalonde J, Plamondon J, Kin NMKNY, Beaulieu S, Joober R, Richard D (2004) Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macro-nutrient selection. Prog Neuro-Psychopharmacol Biol Psychiatry 28:1305-1311
12. Casey DE, Zorn SH (2001) The pharmacology of weight gain with antipsychotics. J Clin Psychiatry 62:4-10
13. Compton MT, Miller AH (2002) Antipsychotic-induced hyperprolactinemia and sexual dysfunction. Psychopharmacol Bull 36:143-164
14. Cooper GD, Pickervance LC, Wildng JPH, Halford JCG, Goudie AJ (2005) A parametric analysis of olanzapine-induced weight gain in female rats. Psychopharmacology (Berl) (in press)
15. Cope MB, Nagy TR, Fernandez JR, Geary N, Casey DE, Allison DB (2005) Antipsychotic drug-induced weight gain: development of an animal model. Int J Obes Relat Metab Disord 29:607-614
16. Cutler AJ (2003) Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology 28(Suppl 1):69-82
17. Daniels AJ, Grizzle M, Strole C, Ignar D, Jones D (2003) Antipsychotic induced weight gain: effects of olanzapine and ziprasidone in female rats. J Psychopharmacol 17:A52
18. Dickson RA, Glazer WM (1999) Neuroleptic-induced hyperprolactinemia. Schizophr Res 35(Suppl):S75-S86
19. Eder U, Mangweth B, Ebenbichler C, Weiss E, Hofer A, Hummer M, Kemmler G, Lechleitner M, Fleischhacker WW (2001) Association of olanzapine-induced weight gain with an increase in body fat. Am J Psychiatry 158:1719-1722
20. Fell MJ, Marshall KM, Neill JC (2004a) Effects of the classical antipsychotic haloperidol and atypical antipsychotic risperidone on weight gain, the oestrous cycle and uterine weight in female rats. Eur Neuropsychopharmacol 14:385-392
21. Fell MJ, Neill JC, Rao C, Marshall KM (2004b) The effect of sulpiride on weight gain, food intake and reproductive function: a comparison between mature and juvenile female rats. J Psychopharmacol 18:A61
22. Fell MJ, Williams J, Marshall KM, Neill JC (2004c) Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats. J Psychopharmacol 18:149-155
23. Fell MJ, Gibson R, McDermott E, Sisodia G, Marshall KM, Neill JC (2005) Investigation into the effects of the novel antipsychotic ziprasidone on weight gain and reproductive function in female rats. Behav Brain Res 160(2):338-343
24. Fox RR, Laird CW (1970) Sexual cycles. In: Hafez ESE (ed) Reproduction and breeding techniques for laboratory animals. Lea & Febiger, Philadelphia
25. Goodnick PJ, Rodriguez L, Santana O (2002) Antipsychotics: impact on prolactin levels. Expert Opin Pharmacother 3:1381-1391
26. Goudie AJ, Smith JA, Halford JC (2002) Characterization of olanzapine-induced weight gain in rats. J Psychopharmacol 16:291-296
27. Green AI, Patel JK, Goisman RM, Allison DB, Blackburn G (2000) Weight gain from novel antipsychotic drugs: need for action. Gen Hosp Psych 22:224-235
28. Hardan A, Hrecnyj B, Johnson K, Johnson C (1996) Case study: risperidone treatment of childern and adolescents with developmental disorders. J Am Acad Child Adolesc Psychiatry 35:1551-1556
29. Hartfield AW, Moore NA, Clifton PG (2003) Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat. Psychopharmacology (Berl) 167:115-122
30. Hellings JA, Zarcone JR, Crandall K, Wallace D, Schroeder SR (2001) Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism. J Child Adolesc Psychopharmacol 11:229-238
31. Kapur S, Zipursky RB, Remington G, Jones C, DaSilva J, Wilson AA, Houle S (1998) 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. Am J Psychiatry 155:921-928
32. Kapur S, VanderSpek SC, Brownlee BA, Nobrega JN (2003) Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy. J Pharmacol Exp Ther 305:625-631
33. Kaur G, Kulkarni SK (2002) Studies on modulation of feeding behavior by atypical antipsychotics in female mice. Prog Neuro-Psychopharmacol Biol Psychiatry 26:277-285
34. Kirk SL, Neill JC, Jones DNC, Reynolds GP (2004) Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the rat. Eur J Pharmacol 505:253-254
35. Kumra S, Frazier JA, Jacobsen LK, McKenna K, Gordon CT, Lenane MC, Hamburger SD, Smith AK, Albus KE, Alaghband-Rad J, Rapoport JL (1996) Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison. Arch Gen Psychiatry 53:1090-1097
36. Mandoki MW (1995) Risperidone Treatment of Children and Adolescents: Increased Risk of Extrapyramidal Side Effects? J Child Adolesc Psychopharmacol 5:49-67
37. National Institute of Health (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. Obes Res 6(Suppl 2):51S-209S
38. Parada MA, Hernandez L, Paez X, Baptista T, Puig de Parada M, de Quijada MU (1989) Mechanism of the body weight increase induced by systemic sulpiride. Pharmacol Biochem Behav 33:45-50
39. Peuskens J (1997) Prolactin elevation and sexual dysfunction. In: Peuskens J (ed) A literature review of prolactin in schizophrenia, clear prospectives: management issues in schizophrenia, vol 1. Franklin Scientific, London pp 17-21
40. Pouzet B, Mow T, Kreilgard M, Velschow S (2003) Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human. Pharmacol Biochem Behav 75(1):133-140
41. Ratzoni G, Gothelf D, Brand-Gothelf A, Reidman J, Kikinzon L, Gal G, Phillip M, Apter A, Weizman R (2002) Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study. J Am Acad Child Adolesc Psych 41:337-343
42. Remschmidt H, Hennighausen K, Clement HW, Heiser P, Schulz E (2000) Atypical neuroleptics in child and adolescent psychiatry. Eur Child Adolesc Psychiatry 9(Suppl 1):I9-I19
43. Reynolds GP (2002) Weight gain, antipsychotic drug treatment and pharmacogenomics. Pharmacogenomics 3:567-570
44. Stigler KA, Potenza MN, Posey DJ, McDougle CJ (2004) Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management. Paediatr Drugs 6:33
45. Taylor DM, McAskill R (2000) Atypical antipsychotics and weight gain - a systematic review. Acta Psychiatr Scand 101:416-432
46. Thornton-Jones Z, Neill JC, Reynolds GP (2002) The atypical antipsychotic olanzapine enhances ingestive behaviour in the rat: a preliminary study. J Psychopharmacol 16:35-37
47. Toren P, Laor N, Weizman A (1998) Use of atypical neuroleptics in child and adolescent psychiatry. J Clin Psychiatry 59:644-656
48. Wade GN, Gray JM (1979) Gonadal effects on food intake and adiposity: a metabolic hypothesis. Physiol Behav 22:583-593
49. Wade GN, Heller HW (1993) Tamoxifen mimics the effects of estradiol on food intake, body weight, and body composition in rats. Am J Physiol 264:R1219-R1223
50. Wade GN, Schneider JE (1992) Metabolic fuels and reproduction in female mammals. Neurosci Biobehav Rev 16:235-272
51. Zuddas A, Pintor M, Cianchetti C (1996) Risperidone for negative symptoms. J Am Acad Child Adolesc Psychiatry 35:838-839